About dalbavancin hydrochloride equivalent to dalbavancin base
Long-acting lipoglycopeptide antibiotic
Used for
- Treats acute bacterial skin and skin-structure infections caused by susceptible bacteria, including certain resistant staphylococci.
Usual adult dose
Adults: 1,500 mg once, or 1,000 mg followed one week later by 500 mg, given by intravenous infusion.
Usual dose in children
Children aged 3 months and older: weight-based intravenous dosing; regimen varies by age and weight.
Common side effects
- Nausea
- Headache
- Diarrhea
- Infusion-related reactions
Important warnings
- Use only for bacterial infections; it does not treat viral infections.
- Serious allergic reactions and severe skin reactions are possible.
- Dose adjustment may be needed in severe kidney impairment when not receiving regular dialysis.
- Prolonged exposure can promote antibiotic resistance.
Pregnancy
Human pregnancy data are limited; use only when clearly needed after weighing potential benefits and risks.
Breastfeeding
It is unknown whether dalbavancin passes into human milk; consider potential effects on the infant and milk production.
Interactions
- May increase the effects of warfarin; monitor clotting tests during and after treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.